EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors-Reference-Cited by-同舟云学术

EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors

Published:2017-02-10 Issue:4 Volume:24 Page:705-716
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Zjablovskaja Polina,Kardosova Miroslava,Danek Petr,Angelisova Pavla,Benoukraf Touati,Wurm Alexander A,Kalina Tomas,Sian Stephanie,Balastik Martin,Delwel Ruud,Brdicka Tomas,Tenen Daniel G,Behre Gerhard,Fiore Fréderic,Malissen Bernard,Horejsi Vaclav,Alberich-Jorda Meritxell

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cdd20176.pdf

Reference29 articles.

1. Orkin SH . Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet 2000; 1: 57–64.

2. Lowenberg B, Downing JR, Burnett A . Acute myeloid leukemia. N Engl J Med 1999; 341: 1051–1062.

3. Ramji DP, Foka P . CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002; 365: 561–575.

4. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG . CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 1998; 18: 4301–4314.

5. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, Owens BM et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004; 21: 853–863.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baker’s yeast beta glucan supplementation was associated with an improved innate immune mRNA expression response after exercise;Methods;2024-10

2. A deep profile of gene expression across 18 human cancers;2024-03-17

3. Assessment of Ecotropic Viral Integration Site 2B (EVI2B) Gene in Juvenile Myelomonocytic Leukemia and Neurofibromatosis Type 1 NF1 Tumors;Biochemical Genetics;2023-08-16

4. EVI2B may be a novel prognostic marker for lung adenocarcinoma;Biomarkers in Medicine;2023-07

5. Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity;ACS Nano;2023-03-13